Jufang Wu

机构：Fudan University, Huashan Hospital · ORCID：0000-0001-8619-0690

发表论文 11 篇 · 总被引 59 次 · h-index 5

代表论文

• Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects (2022 · Frontiers in Pharmacology · 被引 13)
• First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects (2023 · Antimicrobial Agents and Chemotherapy · 被引 9)
• Pharmacokinetics of benapenem for injection in subjects with mild to moderate renal impairment (2022 · European Journal of Clinical Pharmacology · 被引 7)
• Population pharmacokinetics/pharmacodynamics of eravacycline in patients with complicated intra-abdominal infections and community acquired bacterial pneumonia: Support for a fixed-dose treatment regimen (2025 · International Journal of Antimicrobial Agents · 被引 6)
• Comparative assessment of pharmacokinetic parameters between HS016, an adalimumab biosimilar, and adalimumab (Humira®) in healthy subjects and ankylosing spondylitis patients: Population pharmacokinetic modeling (2022 · Advances in Clinical and Experimental Medicine · 被引 6)
• Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes (2024 · Clinical and Translational Science · 被引 5)